AOD-9604 vs Semaglutide: Which Is Better for Weight Loss?
Table of Contents
Comparison Table
| Feature | AOD-9604 | Semaglutide |
|---|---|---|
| Type | Modified HGH fragment (176-191) | GLP-1 receptor agonist |
| Mechanism | Direct lipolysis, inhibits lipogenesis | Appetite suppression, incretin signaling |
| Weight Loss | Modest (limited clinical data) | 15-17% (robust clinical trials) |
| FDA Status | Not approved (GRAS for food use) | FDA approved (Wegovy) |
| Side Effects | Minimal reported | GI effects (nausea, vomiting) |
| Administration | Subcutaneous injection | Weekly subcutaneous injection |
How AOD-9604 Works
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) with an added tyrosine at the C-terminus. It mimics the fat-burning effects of HGH without the growth-promoting or diabetogenic properties. AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) by acting on beta-3 adrenergic receptor pathways.
Unlike HGH, AOD-9604 does not affect IGF-1 levels, blood sugar, or cell proliferation — making it theoretically safer for long-term use. However, clinical weight loss data has been underwhelming compared to expectations.
How Semaglutide Works
Semaglutide suppresses appetite by activating GLP-1 receptors in the hypothalamus, reducing hunger and food intake. It also slows gastric emptying and improves insulin sensitivity. The STEP trials demonstrated 15-17% average weight loss — making it the most effective single-agent anti-obesity drug available.
Beyond weight loss, semaglutide has demonstrated cardiovascular benefits, reduced inflammation, and potential neuroprotective effects.
Head-to-Head: Efficacy
The evidence gap is significant. Semaglutide has multiple large-scale, randomized controlled trials (STEP 1-5, SELECT) demonstrating robust weight loss. AOD-9604's clinical data is much more limited — early trials showed modest fat loss but the peptide never achieved FDA approval for weight management.
Mechanism difference: Semaglutide works centrally (appetite/brain), while AOD-9604 works peripherally (fat tissue). In practice, appetite suppression has proven far more effective for meaningful weight loss than direct lipolysis alone.
Side effects: AOD-9604 has a milder side effect profile. Semaglutide's GI effects (nausea, vomiting) are well-documented, though they typically resolve with titration.
Verdict
For clinically meaningful weight loss, semaglutide is the clear winner with vastly superior evidence and efficacy. AOD-9604 may appeal to those seeking a milder, side-effect-friendly option for modest fat reduction, but expectations should be calibrated accordingly. Some researchers explore combining peripheral and central approaches.
Sourcing
Ascension Peptides offers research-grade AOD-9604 and semaglutide with certificates of analysis and third-party purity verification. Quality matters — always confirm peptide purity before use in research.
Looking for Quality Peptides?
If you're researching peptides, quality sourcing matters. Ascension Peptides offers 99%+ purity with third-party COA testing on every batch.
Explore Ascension Peptides →Affiliate link — we may earn a commission at no extra cost to you
Frequently Asked Questions
Does AOD-9604 actually work for weight loss?
Can you combine AOD-9604 with semaglutide?
Is AOD-9604 safer than semaglutide?
Why wasn't AOD-9604 FDA approved?
Related Peptides
Semaglutide
A GLP-1 receptor agonist originally developed for type 2 diabetes, now the most prescribed weight loss medication worldwide.
Tirzepatide
A dual GIP/GLP-1 receptor agonist showing even greater weight loss results than semaglutide in clinical trials.
Ipamorelin
A selective growth hormone secretagogue that stimulates natural GH release without significantly affecting cortisol or prolactin.
🔬 Looking for quality peptides?
Only buy from suppliers with third-party COA testing.
Ascension Peptides — Verified Supplier →Affiliate link — we may earn a commission.